Procalcitonin as a Predictor of Sepsis and Outcome in Severe Trauma Patients: A Prospective Study
Open Access
- 1 July 2013
- journal article
- research article
- Published by Scientific Scholar in Journal of Laboratory Physicians
- Vol. 5 (02) , 100-108
Abstract
Introduction: Despite the advances in medical sciences, the morbidity and mortality due to sepsis in severe trauma patients remains high; hence the need for early and accurate diagnosis. Very few prospective studies are available in a country like India, which tried to analyze the prediction of sepsis using serum procalcitonin (PCT) in such a large scale among trauma patients. This study explores the role of the biomarker PCT in early diagnosis of sepsis and prediction of outcomes in severe trauma cases. Materials and Methods: We studied the patient population prospectively in two different groups. One with acute trauma but no clinical evidence of sepsis and the second group with clinical evidence of sepsis and are followed. Bronchoalveolar lavage, tracheal aspirates, pus, urine, body fluids from sterile body sites, etc., were collected including blood for culture and serum for PCT assays. Such assays were done on samples collected on days 1 and 4 and then compared. Additionally, C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) levels were also tested. Antimicrobial sensitivity tests were carried out for all the isolates from the clinical samples and correlated with the clinically suspected cases of sepsis. Outcomes of the patients were noted. Results: Patients with high initial PCT levels (>2 ng/ml) in severe trauma cases had poor outcomes and risk of developing complications. Its correlation with severe outcomes was better marked as compared with CRP and ESR levels. The difference in PCT levels between days 1 and 4 in group two patients was statistically significant (P = 0.006) but were not statistically significant for CRP (P = 0.646) and ESR (P = 0.935). The study also shows that PCT levels fall in response to appropriate antimicrobial treatment. Conclusion: PCT is a useful biomarker for early and accurate prediction of sepsis in severe trauma patients. If used in adjunct to clinical findings, it proves to be a good biomarker for early diagnosis, treatment and for monitoring response to therapy in confirmed cases of sepsis. It will prove to be a good supportive indicator of sepsis in early stages for the trauma patients in a low resource country like India.Keywords
This publication has 31 references indexed in Scilit:
- Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patientsCritical Care, 2013
- Changes in Circulating Procalcitonin Versus C-Reactive Protein in Predicting Evolution of Infectious Disease in Febrile, Critically Ill PatientsPLOS ONE, 2013
- Injury-related mortality audit in a regional trauma center at Puducherry, IndiaJournal of Emergencies, Trauma, and Shock, 2012
- Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and futureBMC Medicine, 2011
- Diagnostic accuracy of procalcitonin in critically ill immunocompromised patientsBMC Infectious Diseases, 2011
- Toward an operative diagnosis in sepsis: a latent class approachBMC Infectious Diseases, 2008
- Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumoniaBMC Infectious Diseases, 2007
- Relationship of Phylogenetic Background, Biofilm Production, and Time to Detection of Growth in Blood Culture Vials with Clinical Variables and Prognosis Associated with Escherichia coli BacteremiaJournal of Clinical Microbiology, 2006
- Time to Blood Culture Positivity as a Predictor of Clinical Outcome of Staphylococcus aureus Bloodstream InfectionJournal of Clinical Microbiology, 2006
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992